These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19755962)

  • 1. Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.
    Meza NW; Alonso-Ferrero ME; Navarro S; Quintana-Bustamante O; Valeri A; Garcia-Gomez M; Bueren JA; Bautista JM; Segovia JC
    Mol Ther; 2009 Dec; 17(12):2000-9. PubMed ID: 19755962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo expression of human erythrocyte pyruvate kinase in erythroid cells: a gene therapy approach.
    Meza NW; Quintana-Bustamante O; Puyet A; Rio P; Navarro S; Diez A; Bueren JA; Bautista JM; Segovia JC
    Hum Gene Ther; 2007 Jun; 18(6):502-14. PubMed ID: 17547515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
    Garcia-Gomez M; Calabria A; Garcia-Bravo M; Benedicenti F; Kosinski P; López-Manzaneda S; Hill C; Del Mar Mañu-Pereira M; Martín MA; Orman I; Vives-Corrons JL; Kung C; Schambach A; Jin S; Bueren JA; Montini E; Navarro S; Segovia JC
    Mol Ther; 2016 Aug; 24(7):1187-98. PubMed ID: 27138040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic rescue of hemolytic anemia due to red blood cell pyruvate kinase deficiency.
    Kanno H; Utsugisawa T; Aizawa S; Koizumi T; Aisaki K; Hamada T; Ogura H; Fujii H
    Haematologica; 2007 Jun; 92(6):731-7. PubMed ID: 17550844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
    Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
    PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency.
    Fañanas-Baquero S; Quintana-Bustamante O; Dever DP; Alberquilla O; Sanchez-Dominguez R; Camarena J; Ojeda-Perez I; Dessy-Rodriguez M; Turk R; Schubert MS; Lattanzi A; Xu L; Lopez-Lorenzo JL; Bianchi P; Bueren JA; Behlke MA; Porteus M; Segovia JC
    Mol Ther Methods Clin Dev; 2021 Sep; 22():237-248. PubMed ID: 34485608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.
    Garate Z; Quintana-Bustamante O; Crane AM; Olivier E; Poirot L; Galetto R; Kosinski P; Hill C; Kung C; Agirre X; Orman I; Cerrato L; Alberquilla O; Rodriguez-Fornes F; Fusaki N; Garcia-Sanchez F; Maia TM; Ribeiro ML; Sevilla J; Prosper F; Jin S; Mountford J; Guenechea G; Gouble A; Bueren JA; Davis BR; Segovia JC
    Stem Cell Reports; 2015 Dec; 5(6):1053-1066. PubMed ID: 26549847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.
    Quintana-Bustamante O; Fañanas-Baquero S; Orman I; Torres R; Duchateau P; Poirot L; Gouble A; Bueren JA; Segovia JC
    PLoS One; 2019; 14(10):e0223775. PubMed ID: 31618280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The variable manifestations of disease in pyruvate kinase deficiency and their management.
    Al-Samkari H; Van Beers EJ; Kuo KHM; Barcellini W; Bianchi P; Glenthøj A; Del Mar Mañú Pereira M; Van Wijk R; Glader B; Grace RF
    Haematologica; 2020 Sep; 105(9):2229-2239. PubMed ID: 33054048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro.
    Ayi K; Liles WC; Gros P; Kain KC
    J Infect Dis; 2009 Oct; 200(8):1289-99. PubMed ID: 19743919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency.
    Tani K; Yoshikubo T; Ikebuchi K; Takahashi K; Tsuchiya T; Takahashi S; Shimane M; Ogura H; Tojo A; Ozawa K
    Blood; 1994 Apr; 83(8):2305-10. PubMed ID: 8161797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression.
    Diez A; Gilsanz F; Martinez J; Pérez-Benavente S; Meza NW; Bautista JM
    Blood; 2005 Sep; 106(5):1851-6. PubMed ID: 15870173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
    Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
    Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer.
    Rovira A; De Angioletti M; Camacho-Vanegas O; Liu D; Rosti V; Gallardo HF; Notaro R; Sadelain M; Luzzatto L
    Blood; 2000 Dec; 96(13):4111-7. PubMed ID: 11110681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pyruvate kinase deficiency child with novel PK-LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation.
    Zhan LP; Que LP; Wu ZZ; Liu DD; Wang KM; Xu HG; Fang JP; Huang K
    Pediatr Transplant; 2021 Nov; 25(7):e14078. PubMed ID: 34255916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Al-Samkari H; Addonizio K; Glader B; Morton DH; Chonat S; Thompson AA; Kuo KHM; Ravindranath Y; Wang H; Rothman JA; Kwiatkowski JL; Kung C; Kosinski PA; Al-Sayegh H; London WB; Grace RF
    Br J Haematol; 2021 Mar; 192(6):1092-1096. PubMed ID: 32463523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model.
    Min-Oo G; Fortin A; Tam MF; Gros P; Stevenson MM
    Genes Immun; 2004 May; 5(3):168-75. PubMed ID: 15029238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency.
    Richard RE; Weinreich M; Chang KH; Ieremia J; Stevenson MM; Blau CA
    Blood; 2004 Jun; 103(12):4432-9. PubMed ID: 14988153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients.
    Lesmana H; Dyer L; Li X; Denton J; Griffiths J; Chonat S; Seu KG; Heeney MM; Zhang K; Hopkin RJ; Kalfa TA
    Hum Mutat; 2018 Mar; 39(3):389-393. PubMed ID: 29288557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.